What's New From the CLSI Subcommittee on Antimicrobial Susceptibility TestingByMelANIE T. MAHONEY, MPH, PHARMD STUDENT,Elizabeth B. Hirsch, PharmD, RPH, FIDSAOctober 9th 2019Updates include novel and revised breakpoints for azithromycin, polymyxins, daptomycin, and cefiderocol.